Brief: Silo Pharma announces Formation Of Joint Venture With Hoth Therapeutics
25/06/2025 13:32
June 25 (Reuters) - Hoth Therapeutics Inc HOTH.O: SILO PHARMA: FORMATION OF STRATEGIC JOINT VENTURE WITH HOTH THERAPEUTICS SILO PHARMA: JOINT VENTURE TO DEVELOP FIRST-IN-CLASS GDNF-BASED THERAPY LICENSED FROM U.S. DEPARTMENT OF VETERANS AFFAIRS Source text: ID:nPn4b6dFMa Further company coverage: HOTH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement